uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Application of a combined effect compartment and binding model for gastric acid inhibition of AR-HO47108: a potassium competitive acid blocker, and its active metabolite AR-HO47116 in the dog
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2006 (English)In: European Journal of Pharmaceutical Sciences, ISSN 0928-0987, E-ISSN 1879-0720, Vol. 29, no 2, 91-101 p.Article in journal (Refereed) Published
Abstract [en]

The effect of AR-HO47108, a potassium competitive acid blocker, and its active metabolite AR-HO47116 was studied in Heidenhain pouch dogs following administration of single oral and intravenous doses of the two compounds. The histamine-stimulated acid secretion was measured in different periods after dose up to 24 h. All data obtained in the different studies was pooled and analyzed by non-linear mixed effects modelling.

It was found that there is a delay between the plasma concentration-time peak and the maximum inhibitory effect and that the effect persisted longer than anticipated from the plasma concentration half-lives of the compounds. in addition, it was found that the peak effect was reached earlier at higher doses. The effect data was well described by a combined effect compartment and binding model and both distribution to the biophase i.e. the canaliculus of the parietal cell and a rate limiting binding interaction between drug and enzyme appear to contribute to the observed delay. in addition, a secretion rate dependent washout from the biophase may contribute. Furthermore, because the parent compound and metabolite bind to the same enzyme, the effect is determined by competition between the two for the same enzyme.

The metabolite was found to be less potent than the parent compound, with K-d values of the combined model of 125 and 11.2 nM for the metabolite and parent compound, respectively. However, the metabolite is generated in high concentrations that rapidly exceed the concentration of parent compound after oral administration of parent compound, and this together with its longer plasma half-life will make its contribution to -the overall effect increase with time and slightly prolong the duration of the effect.

Place, publisher, year, edition, pages
2006. Vol. 29, no 2, 91-101 p.
Keyword [en]
PK/PD-modelling, potassium competitive acid blocker, reversible inhibition, gastric acid secretion, dog
National Category
Pharmaceutical Sciences
URN: urn:nbn:se:uu:diva-23892DOI: 10.1016/j.ejps.2006.05.014ISI: 000241372100001PubMedID: 16831536OAI: oai:DiVA.org:uu-23892DiVA: diva2:51666
Available from: 2007-02-01 Created: 2007-02-01 Last updated: 2011-05-27Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Karlsson, Mats O.
By organisation
Department of Pharmaceutical Biosciences
In the same journal
European Journal of Pharmaceutical Sciences
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 196 hits
ReferencesLink to record
Permanent link

Direct link